{
    "ticker": "NNVC",
    "name": "NanoViricides, Inc.",
    "description": "NanoViricides, Inc. is a biotechnology company focused on developing antiviral therapies for a range of viral infections. Founded in 2007 and headquartered in West Haven, Connecticut, the company has pioneered the use of nanotechnology in the development of antiviral drugs. NanoViricides employs a unique approach that utilizes nanomaterials to create specific targeted therapies that can effectively combat viruses, including influenza, herpes, and coronaviruses. Their proprietary technology, known as 'nanoviricides', is designed to mimic the natural interactions between viruses and host cells, allowing for more effective treatment options. The company's lead product candidates are currently in various stages of development and clinical trials, aimed at addressing unmet medical needs in the field of infectious diseases. With a strong emphasis on research and development, NanoViricides collaborates with various academic and industry partners to advance its pipeline of antiviral therapies. The company is dedicated to improving global health outcomes through innovative solutions that target viral pathogens.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "West Haven, Connecticut, USA",
    "founded": "2007",
    "website": "http://www.nanoviricides.com",
    "ceo": "Dr. Anil R. Diwan",
    "social_media": {
        "twitter": "https://twitter.com/NanoViricides",
        "linkedin": "https://www.linkedin.com/company/nanoviricides-inc/"
    },
    "investor_relations": "http://www.nanoviricides.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Anil R. Diwan",
            "position": "CEO"
        },
        {
            "name": "Dr. Robert A. McNulty",
            "position": "President"
        }
    ],
    "product_categories": [
        {
            "category": "Antiviral Therapies",
            "products": [
                "FluCide",
                "HerpesCide",
                "COVID-19 Therapies"
            ]
        }
    ],
    "seo": {
        "meta_title": "NanoViricides, Inc. | Innovative Antiviral Therapies",
        "meta_description": "Explore NanoViricides, Inc., a leader in developing antiviral therapies utilizing nanotechnology. Discover our innovative product pipeline and commitment to combating viral infections.",
        "keywords": [
            "NanoViricides",
            "Antiviral Drugs",
            "Nanotechnology",
            "Biotechnology",
            "Viral Infections",
            "FluCide",
            "COVID-19"
        ]
    },
    "faq": [
        {
            "question": "What is NanoViricides known for?",
            "answer": "NanoViricides is known for developing antiviral therapies using nanotechnology to target specific viruses."
        },
        {
            "question": "Who is the CEO of NanoViricides?",
            "answer": "Dr. Anil R. Diwan is the CEO of NanoViricides, Inc."
        },
        {
            "question": "Where is NanoViricides headquartered?",
            "answer": "NanoViricides is headquartered in West Haven, Connecticut, USA."
        },
        {
            "question": "What are NanoViricides' main products?",
            "answer": "NanoViricides' main products include FluCide, HerpesCide, and therapies for COVID-19."
        },
        {
            "question": "When was NanoViricides founded?",
            "answer": "NanoViricides was founded in 2007."
        }
    ],
    "competitors": [
        "VIR",
        "MRNA",
        "NVAX",
        "GILD"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}